Compare GDDY & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDDY | PEN |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 12.8B |
| IPO Year | 2014 | 2015 |
| Metric | GDDY | PEN |
|---|---|---|
| Price | $86.82 | $322.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 16 |
| Target Price | $136.44 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.9M | 456.0K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 1.60 | 0.82 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $7.94 | $14.34 |
| Revenue Next Year | $6.10 | $13.71 |
| P/E Ratio | ★ $54.91 | $392.78 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $73.06 | $221.26 |
| 52 Week High | $190.50 | $362.41 |
| Indicator | GDDY | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.00 | 37.07 |
| Support Level | $80.41 | $302.19 |
| Resistance Level | $92.66 | $335.61 |
| Average True Range (ATR) | 4.00 | 2.59 |
| MACD | 0.26 | -0.29 |
| Stochastic Oscillator | 35.50 | 11.18 |
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.